STIM Neuronetics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: STIM

Price (delayed)

$3.81

Market cap

$113.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.05

Enterprise value

$116.17M

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial ...

Highlights
Neuronetics's quick ratio has soared by 53% YoY and by 13% from the previous quarter
STIM's EPS is up by 24% YoY and by 11% from the previous quarter
The company's debt has surged by 57% YoY and by 55% QoQ
STIM's equity is down by 40% year-on-year and by 10% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neuronetics.com
Peers: OBIO OM

Key stats

What are the main financial stats of STIM
Market
Shares outstanding
29.76M
Market cap
$113.37M
Enterprise value
$116.17M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.22
Price to sales (P/S)
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
Earnings
Revenue
$71.35M
EBIT
-$24.77M
EBITDA
-$22.76M
Free cash flow
-$34.41M
Per share
EPS
-$1.05
Free cash flow per share
-$1.2
Book value per share
$1.18
Revenue per share
$2.49
TBVPS
$4.04
Balance sheet
Total assets
$115.83M
Total liabilities
$81.64M
Debt
$62.47M
Equity
$34.19M
Working capital
$73.98M
Liquidity
Debt to equity
1.83
Current ratio
4.73
Quick ratio
3.96
Net debt/EBITDA
-0.12
Margins
EBITDA margin
-31.9%
Gross margin
72.5%
Net margin
-42.3%
Operating margin
-42.8%
Efficiency
Return on assets
-29.3%
Return on equity
-72.8%
Return on invested capital
-29.7%
Return on capital employed
-25.8%
Return on sales
-34.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STIM stock price

How has the Neuronetics stock price performed over time
Intraday
8.86%
1 week
9.17%
1 month
-10.14%
1 year
69.33%
YTD
31.38%
QTD
-19.96%

Financial performance

How have Neuronetics's revenue and profit performed over time
Revenue
$71.35M
Gross profit
$51.71M
Operating income
-$30.55M
Net income
-$30.19M
Gross margin
72.5%
Net margin
-42.3%
The company's net margin rose by 26% YoY and by 12% QoQ
The company's operating margin rose by 20% YoY and by 12% QoQ
The net income has grown by 19% YoY and by 9% from the previous quarter
STIM's operating income is up by 13% YoY and by 10% from the previous quarter

Growth

What is Neuronetics's growth rate over time

Valuation

What is Neuronetics stock price valuation
P/E
N/A
P/B
3.22
P/S
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
STIM's EPS is up by 24% YoY and by 11% from the previous quarter
STIM's price to book (P/B) is 101% more than its last 4 quarters average of 1.6 and 34% more than its 5-year quarterly average of 2.4
STIM's equity is down by 40% year-on-year and by 10% since the previous quarter
The P/S is 53% above the last 4 quarters average of 1.0 but 36% below the 5-year quarterly average of 2.4
The revenue has grown by 9% YoY and by 3.1% from the previous quarter

Efficiency

How efficient is Neuronetics business performance
STIM's ROIC is up by 41% YoY and by 24% from the previous quarter
STIM's ROS is up by 31% YoY and by 15% from the previous quarter
The ROE has contracted by 30% YoY and by 3.9% from the previous quarter
The return on assets has increased by 8% since the previous quarter and by 3.6% year-on-year

Dividends

What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STIM.

Financial health

How did Neuronetics financials performed over time
The total assets is 42% more than the total liabilities
STIM's current ratio has soared by 59% YoY and by 2.2% from the previous quarter
Neuronetics's quick ratio has soared by 53% YoY and by 13% from the previous quarter
The company's debt is 83% higher than its equity
STIM's debt to equity has soared by 161% YoY and by 73% QoQ
The company's debt has surged by 57% YoY and by 55% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.